Gebrehiwot Abraham

Summary

Affiliation: Centre for Addiction and Mental Health
Country: Canada

Publications

  1. pmc Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression - an open label trial
    Gaby Abraham
    Mood and Anxiety Program, Centre of Addiction and Mental Health, Department of Psychiatry, University of Toronto, Kingston, Ontario, Canada
    Neuropsychiatr Dis Treat 3:919-24. 2007
  2. ncbi request reprint T3 augmentation of SSRI resistant depression
    Gebrehiwot Abraham
    Department of Psychiatry, University of Toronto, ON, Canada
    J Affect Disord 91:211-5. 2006
  3. ncbi request reprint Clinical outcome and memory function with maintenance electroconvulsive therapy: a retrospective study
    Gebrehiwot Abraham
    Centre for Addiction and Mental Health, West, Toronto, Ontario, Canada
    J ECT 22:43-5. 2006
  4. ncbi request reprint Add-on quetiapine for bipolar depression: a 12-month open-label trial
    Roumen Milev
    Department of Psychiatry, Queen s University, Kingston, Ontario
    Can J Psychiatry 51:523-30. 2006
  5. doi request reprint Quetiapine: novel uses in the treatment of depressive and anxiety disorders
    Arun V Ravindran
    University of Toronto, Ontario, Toronto, Canada
    Expert Opin Investig Drugs 19:1187-204. 2010

Detail Information

Publications5

  1. pmc Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression - an open label trial
    Gaby Abraham
    Mood and Anxiety Program, Centre of Addiction and Mental Health, Department of Psychiatry, University of Toronto, Kingston, Ontario, Canada
    Neuropsychiatr Dis Treat 3:919-24. 2007
    ..RTMS has been developed as a novel tool for treating depression but the clinical significance of this treatment has been variable, especially in the older depressed subjects...
  2. ncbi request reprint T3 augmentation of SSRI resistant depression
    Gebrehiwot Abraham
    Department of Psychiatry, University of Toronto, ON, Canada
    J Affect Disord 91:211-5. 2006
    ..To investigate whether the addition of triiodothyronine (T3) helps relieve depressive symptoms in non-hypothyroid major depressive disorder patients who failed to respond to an adequate course of standard SSRI antidepressant treatments...
  3. ncbi request reprint Clinical outcome and memory function with maintenance electroconvulsive therapy: a retrospective study
    Gebrehiwot Abraham
    Centre for Addiction and Mental Health, West, Toronto, Ontario, Canada
    J ECT 22:43-5. 2006
    ....
  4. ncbi request reprint Add-on quetiapine for bipolar depression: a 12-month open-label trial
    Roumen Milev
    Department of Psychiatry, Queen s University, Kingston, Ontario
    Can J Psychiatry 51:523-30. 2006
    ..Our study also sought to assess the safety and tolerability of quetiapine in patients with BD...
  5. doi request reprint Quetiapine: novel uses in the treatment of depressive and anxiety disorders
    Arun V Ravindran
    University of Toronto, Ontario, Toronto, Canada
    Expert Opin Investig Drugs 19:1187-204. 2010
    ..However, it is often used (off-label) to treat other depressive disorders and anxiety disorders in children and adults...